Track your manuscript:


Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers


No page charges will be levied to authors for the submissions of their review articles for a limited time period (August 13th, 2018 till January 31, 2019).



Abstracted/Indexed in




New eBook

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Endorsements

"Current Alzheimer Research is a great source of the most relevant and timely research in the field of AD research."

Rudolph E. Tanzi
Massachusetts General Hospital, and Harvard Medical School, USA

Forthcoming Special Issues

Systems Genetics of Alzheimer’s disease: From GWAS to Disease Pathways


Guest Editor(s): Keshen Li
Tentative Publication Date: December, 2018
Submit Abstract via Email Download Description
Published Special Issues

Alzehmier's Disease: From Molecular Mechanisms to Psychobiological Perspective


Current Alzheimer Research, Volume 14, Number 11
Guest Editor(s): Mohammad A. Kamal, Nigel H. Greig

Authors' Comments
My experience with Bentham Science Publishers’  "Current Alzheimer Research" was positive. While the review process of the manuscript was a bit too long, on the other hand the great contribution given by the Editor in Chief to the interpretation of the data I presented was brilliant. His suggestions have greatly improved the quality of my manuscript and so at the end my experience was very positive.

Rosanna Squitt
(Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli, Brescia, Italy)


Current Alzheimer Research

,

Volume 15

-

Number 10



Biography   Open Access



Research Article



Research Article



Research Article

Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer’s Disease

, 15(10): 917 - 927

Lili Wan, Jin Lu, Jianliang Fu, Jinlu Huang, Quanjun Yang, Bo Xin, Li Chen, Yan Huo, Yuan Zhong and Cheng Guo*


DOI: 10.2174/1567205015666180601091818


Research Article



Research Article

Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease

, 15(10): 938 - 950

Martina Zverova, Eva Kitzlerova, Zdenek Fisar*, Roman Jirak, Jana Hroudova, Hana Benakova, Petra Lelkova, Pavel Martasek and Jiri Raboch


DOI: 10.2174/1567205015666180601090533


Research Article



Review Article

Progressive Supranuclear Palsy: Neuropsychopathological, Therapeutical and Bioethical Aspects

, 15(10): 959 - 963

Ignazio Vecchio, Cristina Tornali, Giulia Malaguarnera, Nicola Luigi Bragazzi and Michele Malaguarnera*


DOI: 10.2174/1567205015666180507111958


Current Alzheimer Research, Volume 15 (2018) - Number 11


This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print

Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives


Alexandre A. de Castro, Elaine F. F. da Cunha, Ander F. Pereira, Flavia V. Soares, Daniel H. S. Leal, Kamil Kuca and Teodorico C. Ramalho*


View Abstract View on PubMed




Abstracts Ahead of Print


Ezrin expression is increased during disease progression in a tauopathy mouse model and Alzheimer’s disease


Irving E. Vega*, Andrew Umstead, Cassandra M. Wygant, John S. Beck and Scott E. Counts*


View Abstract



Probiotic Supplementation in Patients with Alzheimer’s Dementia – An Explorative Intervention Study


Friedrich Leblhuber, Kostja Steiner, Burkhard Schuetz, Dietmar Fuchs* and Johanna M. Gostner


View Abstract


Improving Cognition through Dance in Older Filipinos with Mild Cognitive Impairment


Jacqueline C. Dominguez*, Maria Clarissa O. del Moral, Jeshya Obeso A. Chio, Ma. Fe P. de Guzman, Boots P. Natividad, Jay-Pee M. Decena, Maryanne Jenelle Y. Montalvo, Macario Reandelar and Kieu T. T. Phung


View Abstract



Influence of Early Life Lead (Pb) exposure on α-Synuclein, GSK-3β and Caspase-3 mediated Tauopathy: Implications on Alzheimer’s disease


Syed Waseem Bihaqi, Bothaina Alansi, Anwar M. Masoud, Foqia Mushtaq, Gehad M. Subaiea and Nasser H. Zawia *


View Abstract


Editor's Choice


Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease

, 2018; 15(10): 938 - 950

Martina Zverova, Eva Kitzlerova, Zdenek Fisar*, Roman Jirak, Jana Hroudova, Hana Benakova, Petra Lelkova, Pavel Martasek and Jiri Raboch


DOI: 10.2174/1567205015666180601090533




(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease

, 2018; 15(9): 883 - 891

Robert E. Becker*, Nigel H. Greig, Debomoy K. Lahiri, Joseph Bledsoe, Sarah Majercik, Clive Ballard, Dag Aarsland, Lon S. Schneider, Douglas Flanagan, Ramprakash Govindarajan, Mary Sano, Luigi Ferrucci and Dimitrios Kapogiannis


DOI: 10.2174/1567205015666180110120026



Memorization Test and Resting State EEG Components in Mild and Subjective Cognitive Impairment

, 2018; 15(9): 809 - 819

Giulia Mazzon*, Federica De Dea, Tatiana Cattaruzza, Paolo Manganotti, Fabrizio Monti and Agostino Accardo


DOI: 10.2174/1567205015666180427114520



Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness

, 2018; 15(9): 848 - 855

Rosie E. Curiel, David A. Loewenstein*, Monica Rosselli, Ailyn Penate, Maria T. Greig-Custo, Russell M. Bauer, Salvador M. Guinjoan, Kevin S. Hanson, Chunfei Li, Gabriel Lizarraga, William W. Barker, Valeria Torres, Steven DeKosky, Malek Adjouadi and Ranjan Duara


DOI: 10.2174/1567205015666180427122746



Treponema, Iron and Neurodegeneration

, 2018; 15(8): 716 - 722

A. Jolivet-Gougeon* and M. Bonnaure-Mallet


DOI: 10.2174/1567205013666161122093404



Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

, 2018; 15(8): 777 - 788

Matthew Davis, Thomas O`Connell, Scott Johnson, Stephanie Cline*, Elizabeth Merikle, Ferenc Martenyi and Kit Simpson


DOI: 10.2174/1567205015666180119092427



Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo

, 2018; 15(8): 731 - 742

José M. Cornejo-Montes-de-Oca, Rebeca Hernández-Soto, Arturo G. Isla, Carlos E. Morado-Urbina and Fernando Peña-Ortega*


DOI: 10.2174/1567205015666180223091233



Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy

, 2018; 15(7): 655 - 663

Joanna K. Chang, Allison Leso, Gehad M. Subaiea, Asma Lahouel, Anwar Masoud, Foqia Mushtaq, Reem Deeb, Aseel Eid, Miriam Dash , Syed W. Bihaqi and Nasser H. Zawia*


DOI: 10.2174/1567205015666180119104036



Open Access Articles

Technological Solutions for Older People with Alzheimer’s Disease: Review

, 2018; 15(10): 975 - 983

Petra Maresova*, Signe Tomsone, Petre Lameski, Joana Madureira, Ana Mendes, Eftim Zdravevski, Ivan Chorbev, Vladimir Trajkovik, Moriah Ellen and Kasper Rodile





Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease

, 2018; 15(10): 938 - 950

Martina Zverova, Eva Kitzlerova, Zdenek Fisar*, Roman Jirak, Jana Hroudova, Hana Benakova, Petra Lelkova, Pavel Martasek and Jiri Raboch




Up-regulation of DMN Connectivity in Mild Cognitive Impairment Via Network-based Cognitive Training

, 2018; 15(6): 578 - 589

Matteo De Marco, Francesca Meneghello, Cristina Pilosio, Jessica Rigon and Annalena Venneri*





Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment

, 2018; 15(5): 482 - 492

Kiyomi Nishimaki, Takashi Asada*, Ikuroh Ohsawa, Etsuko Nakajima, Chiaki Ikejima, Takashi Yokota, Naomi Kamimura and Shigeo Ohta*




Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers

, 2018; 15(2): 164 - 181

Roni Manyevitch, Matthew Protas, Sean Scarpiello, Marisa Deliso, Brittany Bass, Anthony Nanajian, Matthew Chang, Stefani M. Thompson, Neil Khoury, Rachel Gonnella, Margit Trotz, D. Blaine Moore, Emily Harms, George Perry, Lucy Clunes, Angelica Ortiz, Jan O. Friedrich and Ian V.J. Murray*




A Speech Recognition-based Solution for the Automatic Detection of Mild Cognitive Impairment from Spontaneous Speech

, 2018; 15(2): 130 - 138

Laszlo Toth*, Ildiko Hoffmann, Gabor Gosztolya, Veronika Vincze, Greta Szatloczki, Zoltan Banreti, Magdolna Pakaski and Janos Kalman




Biomarkers for Alzheimer's Disease Diagnosis

, 2017; 14(11): 1149 - 1154

Vasileios Mantzavinos and Athanasios Alexiou*




iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer’s Disease

, 2017; 14(10): 1109 - 1122

Nan Li, Pinghong Hu, Tiantian Xu, Huan Chen, Xiaoying Chen, Jianwen Hu, Xifei Yang, Lei Shi, Jian-hong Luo and Junyu Xu*




Association between Periodontal Health Status and Cognitive Abilitie s. The Role of Cytokine Profile and Systemic Inflammation

, 2017; 14(9): 978 - 990

Marta Sochocka*, Maciej Sobczyński , Aleksandra Sender-Janeczek , Katarzyna Zwolińska , Olga Błachowicz , Tomasz Tomczyk, Marek Ziętek and Jerzy Leszek




Kinematic and Pressure Features of Handwriting and Drawing: Preliminary Results Between Patients with Mild Cognitive Impairment, Alzheimer Disease and Healthy Controls

, 2017; 14(9): 960 - 968

Josep Garre-Olmo, Marcos Faúndez-Zanuy, Karmele López-de-Ipiña*, Laia Calvó-Perxas and Oriol Turró-Garriga




Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks

, 2017; 14(8): 870 - 882

Catarina Domingues, Odete A.B. da Cruz e Silva and Ana Gabriela Henriques*




Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice

, 2017; 14(8): 850 - 860

Olaide Oyegbami, Hilary M. Collins, Marie-Christine Pardon, Francis J.P. Ebling, David M. Heery and Paula M. Moran*




Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease

, 2017; 14(7): 696 - 708

Michael Hull*, Carl Sadowsky, Heii Arai, Ghislaine Le Prince Leterme, Ann Holstein, Kevin Booth, Yahong Peng, Tamotsu Yoshiyama, Hideo Suzuki, Nzeera Ketter, Enchi Liu and J. Michael Ryan





Most Cited Articles


Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration

, 2016; 13(2): 185-197.

Tommaso Cassano, Lorenzo Pace, Gaurav Bedse, Angelo Michele Lavecchia, Federico De Marco, Silvana Gaetani and Gaetano Serviddio


DOI: 10.2174/1567205013666151218132725


Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy

, 2016; 13(1): 68-83.

Cristy Phillips, Atoossa Fahimi, Devsmita Das, Fatemeh S. Mojabi, Ravikumar Ponnusamy and Ahmad Salehi


DOI: 10.2174/1567205012666150921095924


Complex and Differential Glial Responses in Alzheimer´s Disease and Ageing

, 2016; 13(4): 343-358.

José J. Rodríguez, Arthur M. Butt, Emanuela Gardenal, Vladimir Parpura and Alexei Verkhratsky


DOI: 10.2174/1567205013666160229112911


Glial Cells – The Key Elements of Alzheimer´s Disease

, 2016; 13(8): 894-911.

David Dzamba, Lenka Harantova, Olena Butenko and Miroslava Anderova


DOI: 10.2174/1567205013666160129095924





Peripheral Immune Signatures in Alzheimer Disease

, 2016; 13(7): 739-749.

David Goldeck, Jacek M. Witkowski, Tamas Fülop and Graham Pawelec


DOI: 10.2174/1567205013666160222112444




Most Accessed Articles


Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

, 2018; 15(8): 777-788.

Matthew Davis, Thomas O`Connell, Scott Johnson, Stephanie Cline*, Elizabeth Merikle, Ferenc Martenyi and Kit Simpson


DOI: 10.2174/1567205015666180119092427



Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment

, 2018; 15(5): 482-492.

Kiyomi Nishimaki, Takashi Asada*, Ikuroh Ohsawa, Etsuko Nakajima, Chiaki Ikejima, Takashi Yokota, Naomi Kamimura and Shigeo Ohta*


DOI: 10.2174/1567205014666171106145017


Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

, 2018; 15(7): 637-642.

M.A. Pappolla*, E. Matsubara, R. Vidal, J. Pacheco-Quinto, B. Poeggeler, M. Zagorski and K. Sambamurti


DOI: 10.2174/1567205015666180411092551


Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease

, 2015; 12(1): 32-46.

Robert J. Baranello, Krishna L. Bharani, Vasudevaraju Padmaraju, Nipun Chopra, Debomoy K. Lahiri, Nigel H. Greig, Miguel A. Pappolla and Kumar Sambamurti


DOI: 10.2174/1567205012666141218140953


Heart Rate Variability Indexes in Dementia: A Systematic Review with a Quantitative Analysis

, 2018; 15(1): 80-88.

Vanessa Pereira da Silva*, Bruno Ribeiro Ramalho Oliveira , Roger Gomes Tavares Mello, Helena Moraes , Andrea Camaz Deslandes and Jerson Laks


DOI: 10.2174/1567205014666170531082352



Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease

, 2018; 15(8): 702-715.

Cassandra Morrison*, Sheida Rabipour, Frank Knoefel, Christine Sheppard and Vanessa Taler


DOI: 10.2174/1567205015666180123123209


Up-regulation of DMN Connectivity in Mild Cognitive Impairment Via Network-based Cognitive Training

, 2018; 15(6): 578-589.

Matteo De Marco, Francesca Meneghello, Cristina Pilosio, Jessica Rigon and Annalena Venneri*


DOI: 10.2174/1567205015666171212103323



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science | Privacy Policy